Drawing for GTE-125

USPTO serial 85514080

GTE-125

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
LEIPZIG, MARC J
Law office
DIVISIONAL UNIT

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GTE-125?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jennifer L. Whitelaw

JENNIFER L. WHITELAW WHITELAW LEGAL GROUP3838 TAMIAMI TRL N STE 310NAPLES, FL 34103-3586UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Botanical extracts for use in the manufacture of nutraceuticals; botanical extracts for use in the manufacture of nutraceuticals and pharmaceuticals; botanical extracts for use in the manufacture of nutraceuticals and pharmaceuticals; chemical extracts and active principles extracted from medicinal plants for use in the manufacture of nutraceuticals and pharmaceuticals, namely, chemical agents made from botanical extracts; chemical extracts and active principles extracted from medicinal plants for use in the pharmaceutical industry, namely, chemical agents made from botanical extracts or association of chemical extracts for use in the manufacture of pharmaceutical or nutraceutical products; botanical extracts for use in the manufacture of medicated preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, lozenges, inhalers, tincture, suppositories and ampule for injection; botanical extracts used in the manufacture of pharmaceutical preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, tincture, suppositories and ampule for injection; botanical extracts for use in the manufacture of pharmaceutical preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, tincture, suppositories and ampule for injection; botanicals and botanical blends, herbals and herbal blends, botanical extracts and botanical extract blends, flavor extracts and flavor extract blends, algal extracts and algal extract blends, all for use in the manufacture of nutritional supplements and vitamins; algal extracts or algal extract blends for use in the manufacture of nutritional and dietary supplements; algal extracts and algal extract blends, all for use in the manufacture of nutritional supplements and vitamins; mushroom, fungus, and spore extracts for use in food manufactureACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 3, 2013MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 2, 2013ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 5, 2013EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 5, 2013NOACCORRECTED NOA E-MAILED—
Feb 4, 2013DPCCDIVISIONAL PROCESSING COMPLETE—
Feb 4, 2013EX1GSOU EXTENSION 1 GRANTED—
Jan 25, 2013AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 24, 2013DRRRDIVISIONAL REQUEST RECEIVED—
Jan 24, 2013EXT1SOU EXTENSION 1 FILED—
Jan 24, 2013ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Jan 24, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 31, 2012NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 5, 2012NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 5, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 16, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 17, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 12, 2012DOCKASSIGNED TO EXAMINER—
Jan 17, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 14, 2012NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance